• Bloomington - Normal Office: 309.452.0995
  • Springfield Office: 217.717.4404
  • After Hours / Emergency Care:
    Call 309.452.0995 or 217.717.4404 and follow the prompts

Current Clinical Trials

Sneeze, Wheeze and Itch Associates, LLC

Go Back

Atopic Dermatitis/Eczema

  • Number
  • Type
  • Age Range
  • Length of Study
  • Compensation*
  • VP-VLY-686-3102
  • Atopic Dermatitis/Eczema
  • 18 - 70 years of age
  • ~ 8 weeks
  • $450

 

*Qualified participants may receive compensation for time and travel, up to the amount listed.

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY STUDY OF THE NEUROKININ-1 RECEPTOR ANTAGONIST VLY-686 IN PATIENTS WITH ATOPIC DERMATITIS

This is a multi-center, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis..

Inclusion Criteria:

  • Male and non-pregnant, non-lactating female patients aged 18 – 70 years (inclusive);
  • Diagnosed with atopic dermatitis;
  • Suffering from chronic pruritus;
  • Body Mass Index (BMI) of ≥18 and ≤40 kg/m2

Exclusion Criteria:

  • Chronic pruritus due to condition other than atopic dermatitis (AD);
  • A positive test for drugs of abuse at the screening or evaluation visits;
  • Exposure to any investigational medication in the past 60 days

For more information, please call 309-452-0995 and ask to speak to a coordinator.